Adenoviren und verfahren zur verwendung von adenoviren

AT1932589TUndetermined Publication Date: 2026-07-15MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: AT2022213285T
Authority / Receiving Office: AT · AT
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2018-11-21
Filing Date: 2019-11-21
Publication Date: 2026-07-15
Estimated Expiration: 2039-11-21

Application Information

Patent Timeline

21 Nov 2018

Priority

21 Nov 2019

Application

AT2022213285T

15 Jul 2026

Publication

AT1932589T

IPC: A61K

Inventors: BARRY, MICHAEL A.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

This invention relates to methods and materials for nucleic acid delivery, vaccination, and / or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and / or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.

Need to check novelty before this filing date? Find Prior Art